B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Current Opinion in Immunology

• Publication date

  2007-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.COI.2007.04.008PMID 17433868
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL.

  2007cited by this paper
• VCAM-1-positive stromal cells from human bone marrow producing cytokines for B lineage progenitors and for plasma cells: SDF-1, flt3L, and BAFF.

  2007cited by this paper
• BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway.

  2007cited by this paper
• Paucity of Clinical Disease despite Serological Autoimmunity and Kidney Pathology in Lupus-Prone New Zealand Mixed 2328 Mice Deficient in BAFF1

  2006cited by this paper
• An APRIL to remember: novel TNF ligands as therapeutic targets

  2006cited by this paper
• Effect of cell:cell competition and BAFF expression on peripheral B cell tolerance and B‐1 cell survival in transgenic mice expressing a low level of Igκ‐reactive macroself antigen

  2006cited by this paper
• Follicular Dendritic Cells Are Related to Bone Marrow Stromal Cell Progenitors and to Myofibroblasts1

  2006cited by this paper
• The role of the BAFF/APRIL system on T cell function.

  2006cited by this paper
• BAFF, APRIL and their receptors: structure, function and signaling.

  2006cited by this paper
• A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys.

  2006cited by this paper
• A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses.

  2006cited by this paper
• Treatment of autoimmune hyperthyroidism in a murine model of Graves' disease with tumor necrosis factor-family ligand inhibitors suggests a key role for B cell activating factor in disease pathology.

  2006cited by this paper
• Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production

  2006cited by this paper
• Reactive oxygen species augment B-cell-activating factor expression.

  2006cited by this paper
• Role of BAFF and APRIL in human B‐cell chronic lymphocytic leukaemia

  2006cited by this paper
• BAFF controls B cell metabolic fitness through a PKCβ- and Akt-dependent mechanism

  2006cited by this paper
• BAFF, APRIL and human B cell disorders.

  2006cited by this paper
• Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity.

  2006cited by this paper
• Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris

  2006cited by this paper
• The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis.

  2006cited by this paper
• Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease.

  2006cited by this paper
• B Cell-Activating Factor Is a Novel Diagnosis Parameter for Asthma

  2006cited by this paper
• A role for BLyS in the activation of innate immune cells.

  2006cited by this paper
• BLyS and B cell homeostasis.

  2006cited by this paper
• Similarities and differences between selective and nonselective BAFF blockade in murine SLE.

  2006cited by this paper
• Rescue of TRAF3-null mice by p100 NF-κB deficiency

  2006cited by this paper
• Regulation of B cell self-tolerance by BAFF.

  2006cited by this paper
• Space, Selection, and Surveillance: Setting Boundaries with BLyS1

  2006cited by this paper
• Updates from B Cell Trials: Efficacy.

  2006cited by this paper
• No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome

  2006cited by this paper
• Airway Epithelial Cells Produce B Cell-Activating Factor of TNF Family by an IFN-β-Dependent Mechanism1

  2006cited by this paper
• BAFF and APRIL as osteoclast-derived survival factors for myeloma cells: a rationale for TACI-Fc treatment in patients with multiple myeloma

  2006cited by this paper
• Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects.

  2006cited by this paper
• B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome

  2006cited by this paper
• Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation.

  2006cited by this paper
• B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia.

  2006cited by this paper
• deltaBAFF, a splice isoform of BAFF, opposes full-length BAFF activity in vivo in transgenic mouse models.

  2005cited by this paper
• BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

  2005cited by this paper
• BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway

  2005cited by this paper
• The role of APRIL and BAFF in lymphocyte activation.

  2005cited by this paper
• The BAFF/APRIL system: life beyond B lymphocytes.

  2005cited by this paper
• A Role for B Cell-Activating Factor of the TNF Family in Chemically Induced Autoimmunity1

  2005cited by this paper
• TACI is mutant in common variable immunodeficiency and IgA deficiency

  2005cited by this paper
• Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis.

  2005cited by this paper
• The BAFF/APRIL System in Systemic Autoimmune Diseases with a Special Emphasis on Sjögren's Syndrome

  2005cited by this paper
• Increased levels of APRIL (a proliferation-inducing ligand) mRNA in multiple sclerosis.

  2005cited by this paper
• The role of BAFF in immune function and implications for autoimmunity

  2005cited by this paper
• The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature.

  2005cited by this paper
• Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha.

  2005cited by this paper
• Fibroblast-Like Synoviocytes of Mesenchymal Origin Express Functional B Cell-Activating Factor of the TNF Family in Response to Proinflammatory Cytokines1

  2005cited by this paper
• BAFF is elevated in serum of patients with Wegener's granulomatosis.

  2005cited by this paper
• The BAFF/APRIL system: an important player in systemic rheumatic diseases.

  2005cited by this paper
• BlySfulness does not equal blissfulness in systemic lupus erythematosus: a therapeutic role for BLyS antagonists.

  2005cited by this paper
• BAFF Overexpression Is Associated with Autoantibody Production in Autoimmune Diseases

  2005cited by this paper
• The biochemistry and biology of BAFF, APRIL and their receptors.

  2005cited by this paper
• ΔBAFF, a Splice Isoform of BAFF, Opposes Full-Length BAFF Activity In Vivo in Transgenic Mouse Models1

  2005cited by this paper
• TNF Deficiency Fails to Protect BAFF Transgenic Mice against Autoimmunity and Reveals a Predisposition to B Cell Lymphoma1

  2004cited by this paper
• B Cell-Activating Factor Belonging to the TNF Family (BAFF)-R Is the Principal BAFF Receptor Facilitating BAFF Costimulation of Circulating T and B Cells1

  2004cited by this paper
• Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase.

  2004cited by this paper
• Regulation of B-cell survival by BAFF-dependent PKCδ-mediated nuclear signalling

  2004cited by this paper
• APRIL promotes B-1 cell-associated neoplasm.

  2004cited by this paper
• Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis

  2004cited by this paper
• TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells.

  2004cited by this paper
• Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival.

  2004cited by this paper
• Regulation of the NF-κB-inducing Kinase by Tumor Necrosis Factor Receptor-associated Factor 3-induced Degradation*

  2004cited by this paper
• BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone.

  2004cited by this paper
• Mechanism of Action of Transmembrane Activator and Calcium Modulator Ligand Interactor-Ig in Murine Systemic Lupus Erythematosus1

  2004cited by this paper
• Impaired IgA class switching in APRIL-deficient mice.

  2004cited by this paper
• Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF.

  2004cited by this paper
• APRIL-Deficient Mice Have Normal Immune System Development

  2004cited by this paper
• Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches.

  2004cited by this paper
• Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome.

  2004cited by this paper
• Act1, a negative regulator in CD40- and BAFF-mediated B cell survival.

  2004cited by this paper
• Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway.

  2004cited by this paper
• Receptor-Specific Signaling for Both the Alternative and the Canonical NF-κB Activation Pathways by NF-κB-Inducing Kinase

  2004cited by this paper
• Cutting Edge: B Cell Receptor Signals Regulate BLyS Receptor Levels in Mature B Cells and Their Immediate Progenitors 1

  2003cited by this paper
• Comparison of Soluble Decoy IgG Fusion Proteins of BAFF-R and BCMA as Antagonists for BAFF*

  2003cited by this paper
• Survival and Proliferation Factors of Normal and Malignant Plasma Cells

  2003cited by this paper
• Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor.

  2003cited by this paper
• A novel polymorphism of the human APRIL gene is associated with systemic lupus erythematosus.

  2003cited by this paper
• Studies of Structure-Activity Relations of Complement Inhibitor Compstatin1

  2003cited by this paper
• Normal B Cell Homeostasis Requires B Cell Activation Factor Production by Radiation-resistant Cells

  2003cited by this paper
• BAFF AND APRIL: a tutorial on B cell survival.

  2003cited by this paper
• BAFF selectively enhances the survival of plasmablasts generated from human memory B cells.

  2003cited by this paper
• The TNF family members BAFF and APRIL: the growing complexity.

  2003cited by this paper
• EBV-Encoded Latent Membrane Protein 1 Cooperates with BAFF/BLyS and APRIL to Induce T Cell-Independent Ig Heavy Chain Class Switching 1

  2003cited by this paper
• Critical Roles for Rac1 and Rac2 GTPases in B Cell Development and Signaling

  2003cited by this paper
• ΔBAFF, an Alternate Splice Isoform That Regulates Receptor Binding and Biopresentation of the B Cell Survival Cytokine, BAFF*

  2003cited by this paper
• Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator.

  2003cited by this paper
• Analysis of an Ethylnitrosourea-generated Mouse Mutation Defines a Cell Intrinsic Role of Nuclear Factor κB2 in Regulating Circulating B Cell Numbers

  2002cited by this paper
• BLyS and BLyS receptor expression in non-Hodgkin's lymphoma.

  2002cited by this paper
• DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL

  2002cited by this paper
• The molecular architecture of the TNF superfamily.

  2002cited by this paper
• BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells

  2002cited by this paper
• Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis

  2002cited by this paper
• Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival.

  2002cited by this paper
• B lymphocyte stimulator protein-associated increase in circulating autoantibody levels may require CD4+ T cells: lessons from HIV-infected patients.

  2002cited by this paper
• BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.

  2002cited by this paper
• Homeostatic control of lymphocyte survival: potential origins and implications

  2002cited by this paper
• BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells.

  2002cited by this paper

• Effect of Red Blood Cell Transfusion on Inflammatory and Angiogenic Pathways in Patients With Sickle Cell Disease.

  2026cites this paper
• IgA defects in CVID lead to bacterial translocation, increased serum γ-interferon, and BAFF

  2026cites this paper
• Single-cell transcriptomics reveals phenotypic and functional alterations of erythroid progenitor cells in tuberculosis patients.

  2026cites this paper
• Autoimmune disease and risk of lymphoma: analysis from real-world data and Mendelian randomization study

  2025cites this paper
• Efficacy and safety of belimumab versus rituximab for refractory immune thrombocytopenia in patients with connective tissue disease

  2025cites this paper
• Serum cytokines in periodontal diseases

  2025cites this paper
• Longitudinal Immune Profiling in Autoimmune Polyendocrine Syndrome Type 1

  2025cites this paper
• Povetacicept (ALPN-303; TACI vTD-Fc), an enhanced, potent dual inhibitor of BAFF and APRIL, ameliorates experimental autoimmune myasthenia gravis in C57BL/6N mice

  2025cites this paper
• Substituted 2-pyrrolinone compounds as inhibitors of B-cell activating factor (BAFF) for autoimmune diseases treatment.

  2025cites this paper
• Peripheral immune reactions following human traumatic spinal cord injury: the interplay of immune activation and suppression

  2024cites this paper
• Novel B cell subsets as potential biomarkers in Idiopathic Inflammatory Myopathies: insights into disease pathogenesis and disease activity.

  2024cites this paper
• Characterization of Inflammation/Immune‐, Acute Phase‐, Extracellular Matrix‐, Adhesion‐, and Serine Protease‐Related Proteins in the Amniotic Fluid of Women With Early Preterm Prelabor Rupture of Membranes

  2024cites this paper
• Role of telitacicept in the treatment of IgA nephropathy

  2023cites this paper
• Pre- and Post-treatment Serum BAFF Levels and BAFF Gene Polymorphisms in Patients with Graves’ Disease

  2023cites this paper
• Disease in the Pld4thss/thss Model of Murine Lupus Requires TLR9

  2023cites this paper
• Induced Overexpression of B Cell-Activating Factor by Triiodothyronine Results in Abnormal B Cell Differentiation in Mice

  2023cites this paper
• BAFF and APRIL counterregulate susceptibility to inflammation-induced preterm birth

  2023cites this paper
• Efficacy and safety of telitacicept in patients with systemic lupus erythematosus: a multicentre, retrospective, real-world study

  2023cites this paper
• The causal relationship between multiple autoimmune diseases and nasal polyps

  2023cites this paper
• Novel contributors to B cell activation during inflammatory CNS demyelination; An oNGOing process

  2022influential citation
• APRIL and BAFF play a key role in differentiating vitreoretinal lymphoma from uveitis.

  2022cites this paper
• Thyroid hormone induces B cells abnormal differentiation via overexpression of B cell-activating factor

  2022cites this paper
• Inflammation and Oxidative Stress as Common Mechanisms of Pulmonary, Autonomic and Musculoskeletal Dysfunction after Spinal Cord Injury

  2022cites this paper
• Antibody microarray analysis of amniotic fluid proteomes in women with cervical insufficiency and short cervix, and their association with pregnancy latency length

  2022cites this paper
• Role of peripheral immune cells in spinal cord injury

  2022cites this paper
• Antibody microarray analysis of the amniotic fluid proteome for predicting the outcome of rescue cerclage in patients with cervical insufficiency

  2021cites this paper
• Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107

  2021cites this paper
• The emerging field of regulatory B cell immunometabolism.

  2021cites this paper
• BAFF signaling in health and disease.

  2021cites this paper
• Impaired B Cell Apoptosis Results in Autoimmunity That Is Alleviated by Ablation of Btk

  2021cites this paper
• Possible interplay between estrogen and the BAFF may modify thyroid activity in Graves’ disease

  2021cites this paper
• BAFF receptor polymorphisms and deficiency in humans.

  2021cites this paper
• Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems

  2021cites this paper
• High B‐cell activating factor levels in multi‐transfused thalassemia patients

  2021cites this paper
• Insights Into the Pathologic Roles and Regulation of Eukaryotic Elongation Factor-2 Kinase

  2021cites this paper
• Rapamycin inhibits B-cell activating factor (BAFF)-stimulated cell proliferation and survival by suppressing Ca2+-CaMKII-dependent PTEN/Akt-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cells.

  2020influential citation
• Bacterial Lipoproteins Induce BAFF Production via TLR2/MyD88/JNK Signaling Pathways in Dendritic Cells

  2020cites this paper
• Local eosinophils are associated with increased IgA subclass levels in the sinonasal mucosa of chronic rhinosinusitis with polyp patients

  2020cites this paper
• Signi cance of Immune-related Genes in the Diagnosis and Subtype Classi cation of Childhood Asthma

  2020cites this paper
• Regulation of tumor necrosis superfamily molecules, BAFF and APRIL, in response to pathogenic exposure and ligand stimulation in freshwater carp, Catla catla

  2020cites this paper
• Management Considerations: Juvenile Dermatomyositis

  2019cites this paper
• Phenotypic and functional B-cell ontogenesis

  2019cites this paper
• Depletion of B cell-activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease

  2019cites this paper
• Therapeutic effects of a novel BAFF blocker on arthritis

  2019cites this paper
• TNFSF13B correlated with poor prognosis and immune infiltrates in KIRC: a study based on TCGA data

  2019cites this paper
• APRIL and BAFF: novel biomarkers for central nervous system lymphoma

  2019cites this paper
• Molecular structure, expression, and bioactivity of B-cell-activating factor of the TNF family (BAFF) and its receptor BAFF-R in cats (Felis catus).

  2019cites this paper
• Rapamycin attenuates BAFF‐extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B‐lymphoid cells

  2018cites this paper
• Correlation of APRIL with production of inflammatory cytokines during acute malaria in the Brazilian Amazon

  2018cites this paper
• Enhanced Interferon-β Response Contributes to Eosinophilic Chronic Rhinosinusitis

  2018cites this paper
• Paeoniflorin-6′-O-benzene sulfonate alleviates collagen-induced arthritis in mice by downregulating BAFF-TRAF2-NF-κB signaling: comparison with biological agents

  2018cites this paper
• The presence of anti-nuclear antibodies alone is associated with changes in B cell activation and T follicular helper cells similar to those in systemic autoimmune rheumatic disease

  2018cites this paper
• Genetic assessment of inbred chicken lines indicates genomic signatures of resistance to Marek’s disease

  2018cites this paper
• Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions.

  2018cites this paper
• Assessment of serum a proliferation-induced ligand level in patients with pemphigus vulgaris

  2018cites this paper
• Blockade of BAFF Receptor BR3 on T Cells Enhances Their Activation and Cytotoxicity

  2018cites this paper
• Induction of Hypergammaglobulinemia and Autoantibodies by Salmonella Infection in MyD88-Deficient Mice

  2018cites this paper
• New insights into the pathophysiology of IgG4-related disease and markers of disease activity

  2018cites this paper
• BAFF and CD4+ T cells are major survival factors for long-lived splenic plasma cells in a B-cell-depletion context.

  2018cites this paper
• Novel Drugs in Kidney Transplantation

  2017cites this paper
• The BAFF / APRIL axis plays an important role in virus‐induced peritoneal responses in rainbow trout

  2017cites this paper
• Effect of Dietary Vitamin C on Growth Performance , Antioxidant Status and Innate Immunity of Juvenile Pufferfish ( Takifugu obscurus )

  2017cites this paper
• Autoantibodies against BAFF, APRIL or IL21 - an alternative pathogenesis for antibody-deficiencies?

  2017cites this paper
• Present and future of biologic drugs in primary Sjögren’s syndrome

  2017cites this paper
• Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome

  2016cites this paper
• Decreased somatic hypermutation induces an impaired peripheral B cell tolerance checkpoint.

  2016cites this paper
• Étude du niveau de B Lymphocyte Stimulator (BLyS) et de son impact sur les lymphocytes B en relation avec l’infection et la résistance au virus d’immunodéficience humaine (VIH) chez des travailleuses du sexe au Bénin

  2016cites this paper
• IgG4-Related Disease and Innate Immunity.

  2016cites this paper
• Reduced Number of Transitional and Naive B Cells in Addition to Decreased BAFF Levels in Response to the T Cell Independent Immunogen Pneumovax®23

  2016cites this paper
• Serum BAFF and peripheral blood CD19+ B-lymphocytes in generalized vitiligo and relation to disease activity

  2016cites this paper
• IL-2, IL-4, IFN-γ or TNF-α enhances BAFF-stimulated cell viability and survival by activating Erk1/2 and S6K1 pathways in neoplastic B-lymphoid cells.

  2016cites this paper
• New Strategies in Multiple Sclerosis Therapy International Journal of Autoimmune Disorders & Therapy

  2016cites this paper
• 2 IgG 4-Related Disease ( IgG 4-RD ) and Microbe-Associated Molecular Patterns ( MAMPs ) and Damage-Associated Molecular Patterns ( DAMPs ) 2 . 1 MAMPs and DAMPs

  2016cites this paper
• Immunoglobulin-induced hemolysis, splenomegaly and inflammation in patients with antibody deficiencies

  2016cites this paper
• Deficiency of the B Cell-Activating Factor Receptor Results in Limited CD169+ Macrophage Function during Viral Infection

  2015cites this paper
• Increased Serum B Cell Activating Factor and a Proliferation-inducing Ligand Are Associated with Interstitial Lung Disease in Patients with Juvenile Dermatomyositis

  2015cites this paper
• Immunopathology of chronic rhinosinusitis.

  2015cites this paper
• Characterization of the Immune Basis for Reduced IFN-alpha in Serologically Active Clinically Quiescent SLE Patients

  2015cites this paper
• Estimation of the serum level of a proliferation-inducing ligand in patients with psoriasis and lichen planus

  2015cites this paper
• The comparison of BLyS-binding peptides from phage display library and computer-aided design on BLyS-TACI interaction.

  2015cites this paper
• The DermatomyositisAre Associated with Interstitial Lung Disease in Patients with Juvenile Increased Serum B Cell Activating Factor and a Proliferation-inducing Ligand

  2015cites this paper
• Cell extrinsic alterations in splenic B cell maturation in Flt3-ligand knockout mice

  2015influential citation
• TNF superfamily protein-protein interactions: feasibility of small- molecule modulation.

  2015cites this paper
• Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cells

  2015cites this paper
• Pattern Recognition Receptors and the Innate Immune Network

  2015cites this paper
• Developmental Toxicity and Fertility Assessment in Rabbits with Tabalumab: A Human IgG4 Monoclonal Antibody.

  2015cites this paper
• Characterisation of inflammatory processes in Helicobacter pylori-induced gastric lymphomagenesis in a mouse model

  2015cites this paper
• An Enhanced Pre- and Postnatal Development Study in Cynomolgus Monkeys with Tabalumab: A Human IgG4 Monoclonal Antibody.

  2015cites this paper
• Evaluation of biochemical parameters and local and systemic levels of osteoactive and B-cell stimulatory factors in gestational diabetes in the presence or absence of gingivitis.

  2015cites this paper
• Molecular and functional characterization of BAFF from the Yangtze alligator (Alligator sinensis, Alligatoridae).

  2015cites this paper
• Comparative analysis of laparoscopic and ultrasound-guided biopsy methods for gene expression analysis in transgenic goats.

  2015cites this paper
• CsBAFF, a Teleost B Cell Activating Factor, Promotes Pathogen-Induced Innate Immunity and Vaccine-Induced Adaptive Immunity

  2015cites this paper
• Characterization of the Immune Basis for Reduced IFN-α in Serologically Active Clinically Quiescent SLE Patients

  2015cites this paper
• Role of BAFF in pediatric patients with allergic rhinitis during sublingual immunotherapy

  2014cites this paper
• Regulatory immune cytokines in RSV infection

  2014cites this paper
• Raised Expression of APRIL in Chinese Children With Acute Lymphoblastic Leukemia and its Clinical Implications

  2014cites this paper
• Evidence and Role of Autoantibodies in Chronic Rhinosinusitis with Nasal Polyps

  2014cites this paper
• Lymphocytes and autoimmunity after spinal cord injury.

  2014cites this paper
• BAFF activates Erk1/2 promoting cell proliferation and survival by Ca2+-CaMKII-dependent inhibition of PP2A in normal and neoplastic B-lymphoid cells.

  2014cites this paper
• The role of B cell Activating Factor (BAFF) expression on pathogenesis of nasal polyp in chronic rhinosinusitis with nasal polyposis.

  2014cites this paper